Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Axogen (AXGN) EBT Margin (2016 - 2025)

Historic EBT Margin for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to 0.79%.

  • Axogen's EBT Margin rose 47200.0% to 0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.26%, marking a year-over-year increase of 73600.0%. This contributed to the annual value of 5.53% for FY2024, which is 88200.0% up from last year.
  • As of Q3 2025, Axogen's EBT Margin stood at 0.79%, which was up 47200.0% from 0.14% recorded in Q2 2025.
  • Axogen's EBT Margin's 5-year high stood at 1.1% during Q4 2024, with a 5-year trough of 37.8% in Q1 2022.
  • In the last 5 years, Axogen's EBT Margin had a median value of 14.3% in 2022 and averaged 13.74%.
  • In the last 5 years, Axogen's EBT Margin crashed by -184900bps in 2021 and then soared by 192300bps in 2023.
  • Axogen's EBT Margin (Quarter) stood at 16.71% in 2021, then grew by 14bps to 14.3% in 2022, then grew by 23bps to 10.95% in 2023, then soared by 110bps to 1.1% in 2024, then dropped by -28bps to 0.79% in 2025.
  • Its EBT Margin stands at 0.79% for Q3 2025, versus 0.14% for Q2 2025 and 7.49% for Q1 2025.